Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded

Hemamali Samaratunga, Brett Delahunt, Lars Egevad, John R. Srigley, Athanase Billis, David G. Bostwick, Philippe Camparo, Liang Cheng, David Clouston, James Denham, Bungo Furusato, Arndt Hartmann, Laura Jufe, James Kench, Diane N. Kenwright, Glen Kristiansen, Katia R.M. Leite, Gregory T. MacLennan, Jennifer Merrimen, Holger MochJon Oxley, Chin Chen Pan, Gladell Paner, Jae Ro, Isabell A.M. Sesterhenn, Jonathan Shanks, Michelle Thunders, Toyonori Tsuzuki, Thomas Wheeler, John W. Yaxley, Murali Varma

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

32 Citas (Scopus)

Resumen

Infiltration of the prostatic ducts by prostatic adenocarcinoma occurs relatively frequently, being most commonly associated with high grade disease. It is now recognised that intraductal carcinoma of the prostate (IDCP) has an associated poor prognosis and this is reflected in its histological, molecular and immunohistochemical features. The current recommendation of the World Health Organization is that IDCP not be taken into consideration when grading prostate adenocarcinoma. It is apparent that Gleason did not differentiate between IDCP and stromal invasive carcinoma when developing and validating his grading system, and recent studies suggest that the incorporation of IDCP grading into the overall grading of the specimen provides additional prognostic information.

Idioma originalEnglish
Páginas (desde-hasta)192-196
Número de páginas5
PublicaciónPathology
Volumen52
N.º2
DOI
EstadoPublished - feb. 2020
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
© 2019 Royal College of Pathologists of Australasia

ASJC Scopus Subject Areas

  • Pathology and Forensic Medicine

Huella

Profundice en los temas de investigación de 'Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded'. En conjunto forman una huella única.

Citar esto